검색결과 : 23건
| No. | Article |
|---|---|
| 1 |
The Wnt3a/beta-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab Shen GD, Gao Q, Liu FF, Zhang Y, Dai M, Zhao TT, Cheng M, Xu TJ, Jin PP, Yin W, Huang DB, Weng HY, Chen W, Ren HR, Mu XX, Wu XC, Hu SL Biochemical and Biophysical Research Communications, 526(3), 685, 2020 |
| 2 |
POU4F1 confers trastuzumab resistance in HER2-positive breast cancer through regulating ERK1/2 signaling pathway Wu D, Jia HY, Wei N, Li SJ Biochemical and Biophysical Research Communications, 533(3), 533, 2020 |
| 3 |
Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations Kayatani H, Ohashi K, Ninomiya K, Makimoto G, Nishii K, Higo H, Watanabe H, Kano H, Kato Y, Ninomiya T, Kubo T, Rai K, Ichihara E, Hotta K, Tabata M, Maeda Y, Kiura K Biochemical and Biophysical Research Communications, 532(3), 341, 2020 |
| 4 |
Click chemistry-mediated tumor-targeting of SN38-loaded nanoparticles using trastuzumab Yoo J, Choi S, Son J, Yi G, Kim E, Koo H Biochemical and Biophysical Research Communications, 515(1), 207, 2019 |
| 5 |
Recombinant cucurmosin-based immunotoxin targeting HER-2 with potent in vitro anti-cancer cytotoxicity Xiong JN, Zhang CY, Wu SF, Gu XF, Cai YM, Xu CS, Chen Z, Sun JC, Wu XX, You XH, Huang ZH, Xie JM Biochemical and Biophysical Research Communications, 513(1), 15, 2019 |
| 6 |
Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1 Zhu HY, Bai WD, Ye XM, Yang AG, Jia LT Biochemical and Biophysical Research Communications, 496(4), 1308, 2018 |
| 7 |
Dynamic microRNA activity identifies therapeutic targets in trastuzumab-resistant HER2(+) breast cancer Decker JT, Hall MS, Blaisdell RB, Schwark K, Jeruss JS, Shea LD Biotechnology and Bioengineering, 115(10), 2613, 2018 |
| 8 |
Trastuzumab stimulation of ribosomal protein S6 kinase 1 (S6K1) predicts de novo trastuzumab resistance Huynh FC, Nguyen D, Jones FE Biochemical and Biophysical Research Communications, 483(1), 739, 2017 |
| 9 |
Synergistic anti-tumor activity of Nimotuzumab in combination with Trastuzumab in HER2-positive breast cancer Yang Y, Guo R, Tian XT, Zhang ZH, Zhang PF, Li CZ, Feng ZW Biochemical and Biophysical Research Communications, 489(4), 523, 2017 |
| 10 |
Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models Morimura O, Minami T, Kijima T, Koyama S, Otsuka T, Kinehara Y, Osa A, Higashiguchi M, Miyake K, Nagatomo I, Hirata H, Iwahori K, Takimoto T, Takeda Y, Kida H, Kumanogoh A Biochemical and Biophysical Research Communications, 488(4), 596, 2017 |